Comparison of the precision and sensitivity of the antivirogram and PhenoSense HIV drug susceptibility assaysJIE ZHANG; RHEE, Soo-Yon; TAYLOR, Jonathan et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 38, Num 4, pp 439-444, issn 1525-4135, 6 p.Article

Consensus drug resistance mutations for epidemiological surveillance : basic principles and potential controversiesSHAFER, Robert W; RHEE, Soo-Yon; BENNETT, Diane E et al.Antiviral therapy (London). 2008, Vol 13, pp 59-68, issn 1359-6535, 10 p., SUP2Article

Constrained patterns of covariation and clustering of HIV-1 non-nucleoside reverse transcriptase inhibitor resistance mutationsREUMAN, Elizabeth C; RHEE, Soo-Yon; HOLMES, Susan P et al.Journal of antimicrobial chemotherapy (Print). 2010, Vol 65, Num 7, pp 1477-1485, issn 0305-7453, 9 p.Article

HIV-1 Integrase Sequence Variability in Antiretroviral Naïve Patients and in Triple-Class Experienced Patients Subsequently Treated with RaltegravirVARGHESE, Vici; LIU, Tommy F; RHEE, Soo-Yon et al.AIDS research and human retroviruses. 2010, Vol 26, Num 12, pp 1323-1326, issn 0889-2229, 4 p.Article

The calibrated population resistance tool : standardized genotypic estimation of transmitted HIV-1 drug resistanceGIFFORD, Robert J; LIU, Tommy F; RHEE, Soo-Yon et al.Bioinformatics (Oxford. Print). 2009, Vol 25, Num 9, pp 1197-1198, issn 1367-4803, 2 p.Article

Sequence editing by Apolipoprotein B RNA-editing catalytic component-B and epidemiological surveillance of transmitted HIV-1 drug resistanceGIFFORD, Robert J; RHEE, Soo-Yon; ERIKSSON, Nicolas et al.AIDS (London). 2008, Vol 22, Num 6, pp 717-725, issn 0269-9370, 9 p.Article

Virologic efficacy of boosted double versus boosted single protease inhibitor therapyPETERSEN, Maya L; YUE WANG; VAN DER LAAN, Mark J et al.AIDS (London). 2007, Vol 21, Num 12, pp 1547-1554, issn 0269-9370, 8 p.Article

Sequencing-based detection of low-frequency human immunodeficiency virus type 1 drug-resistant mutants by an RNA/DNA heteroduplex generator-tracking assayKAPOOR, Amit; JONES, Morris; SHAFER, R. W et al.Journal of virology. 2004, Vol 78, Num 13, pp 7112-7123, issn 0022-538X, 12 p.Article

Lack of detectable human hununodeficiency virus type 1 superinfection during 1072 person-years of observationGONZALES, Matthew J; DELWART, Eric; RHEE, Soo-Yon et al.The Journal of infectious diseases. 2003, Vol 188, Num 3, pp 397-405, issn 0022-1899, 9 p.Article

HIV-1 protease and reverse transcriptase mutations for drug resistance surveillanceSHAFER, Robert W; RHEE, Soo-Yon; PILLAY, Deenan et al.AIDS (London). 2007, Vol 21, Num 2, pp 215-223, issn 0269-9370, 9 p.Article

Prevalence of darunavir resistance-associated mutations : Patterns of occurrence and association with past treatment. CommentaryHAUBRICH, Richard; MITSUYA, Yumi; LIU, Tommy F et al.The Journal of infectious diseases. 2007, Vol 196, Num 8, issn 0022-1899, 1125-1127, 1177-1179 [6 p.]Article

Panel of prototypical infectious molecular HIV-1 clones containing multiple nucleoside reverse transcriptase inhibitor resistance mutationsJOHNSTON, Elizabeth; DUPNIK, Kathryn M; GONZALES, Matthew J et al.AIDS (London). 2005, Vol 19, Num 7, pp 731-733, issn 0269-9370, 3 p.Article

Minority Variants Associated with Transmitted and Acquired HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor Resistance: Implications for the Use of Second-Generation Nonnucleoside Reverse Transcriptase InhibitorsVARGHESE, Vici; SHAHRIAR, Rajin; BACHMANN, Michael H et al.Journal of acquired immune deficiency syndromes (1999). 2009, Vol 52, Num 3, pp 309-315, issn 1525-4135, 7 p.Article

Nonpolymorphic Human Immunodeficiency Virus Type 1 Protease and Reverse Transcriptase Treatment-Selected MutationsSHAHRIAR, Rajin; RHEE, Soo-Yon; LIU, Tommy F et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 11, pp 4869-4878, issn 0066-4804, 10 p.Article

HIV-1 drug resistance genotype results in patients with plasma samples with HIV-1 RNA levels less than 75 copies/mlMITSUYA, Yumi; WINTERS, Mark A; FESSEL, W. Jeffrey et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 1, pp 56-59, issn 1525-4135, 4 p.Article

Predicting the Response to Combination Antiretroviral Therapy : Retrospective Validation of geno2pheno-THEO on a Large Clinical DatabaseALTMANN, André; DÄUMER, Martin; ZAZZI, Maurizio et al.The Journal of infectious diseases. 2009, Vol 199, Num 7, pp 999-1006, issn 0022-1899, 8 p.Article

HIV-1 pol mutation frequency by subtype and treatment experience : extension of the HIVseq program to seven non-B subtypesRHEE, Soo-Yon; KANTOR, Rami; KATZENSTEIN, David A et al.AIDS (London). 2006, Vol 20, Num 5, pp 643-651, issn 0269-9370, 9 p.Article

Nucleoside Reverse Transcriptase Inhibitor Resistance Mutations Associated with First-Line Stavudine-Containing Antiretroviral Therapy: Programmatic Implications for Countries Phasing Out StavudineTANG, Michele W; RHEE, Soo-Yon; RUXRUNGTHAM, Kiat et al.The Journal of infectious diseases. 2013, Vol 207, issn 0022-1899, S70-S77, SUP2Article

Hepatitis B virus reverse transcriptase sequence variant database for sequence analysis and mutation discoveryRHEE, Soo-Yon; MARGERIDON-THERMET, Severine; NGUYEN, Mindie H et al.Antiviral research. 2010, Vol 88, Num 3, pp 269-275, issn 0166-3542, 7 p.Article

Predictive Value of HIV 1 Genotypic Resistance Test Interpretation AlgorithmsRHEE, Soo-Yon; FESSEL, W. Jeffrey; TAYLOR, Jonathan et al.The Journal of infectious diseases. 2009, Vol 200, Num 3, pp 453-463, issn 0022-1899, 11 p.Article

Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistanceALTMANN, André; BEERENWINKEL, Niko; SING, Tobias et al.Antiviral therapy (London). 2007, Vol 12, Num 2, pp 169-178, issn 1359-6535, 10 p.Article

HIV-1 protease and reverse-transcriptase mutations : Correlations with antiretroviral therapy in subtype B isolates and implications for drug-resistance surveillanceRHEE, Soo-Yon; FESSEL, W. Jeffrey; FLAMM, Jason et al.The Journal of infectious diseases. 2005, Vol 192, Num 3, pp 456-465, issn 0022-1899, 10 p.Article